Portfolio company
Avery Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Avery Therapeutics develops tissue-engineered heart grafts to treat patients with chronic heart failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
Heartseed
Heartseed develops cell-based regenerative therapies and transplantation devices for patients with severe heart failure and other cardiac diseases.
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
Artifex
This company develops artificial vascular grafts for patients undergoing coronary and peripheral bypass surgery.
Corvivo
Corvivo Cardiovascular develops regenerative medical devices for surgeons to repair damaged heart valves and cardiac tissue in adult and paediatric patients.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.